Search Results - "Huu Duong, Thai"

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam by Duc Dang, Anh, Dinh Vu, Thiem, Hai Vu, Ha, Thanh Ta, Van, Thi Van Pham, Anh, Thi Ngoc Dang, Mai, Van Le, Be, Huu Duong, Thai, Van Nguyen, Duoc, Lawpoolsri, Saranath, Chinwangso, Pailinrut, McLellan, Jason S., Hsieh, Ching-Lin, Garcia-Sastre, Adolfo, Palese, Peter, Sun, Weina, Martinez, Jose L., Gonzalez-Dominguez, Irene, Slamanig, Stefan, Manuel Carreño, Juan, Tcheou, Johnstone, Krammer, Florian, Raskin, Ariel, Minh Vu, Huong, Cong Tran, Thang, Mai Nguyen, Huong, Mercer, Laina D., Raghunandan, Rama, Lal, Manjari, White, Jessica A., Hjorth, Richard, Innis, Bruce L., Scharf, Rami

“…Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and middle-income countries is needed. NDV-HXP-S is an inactivated egg-based…”
Get full text

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses by Sun, Weina, Liu, Yonghong, Amanat, Fatima, González-Domínguez, Irene, McCroskery, Stephen, Slamanig, Stefan, Coughlan, Lynda, Rosado, Victoria, Lemus, Nicholas, Jangra, Sonia, Rathnasinghe, Raveen, Schotsaert, Michael, Martinez, Jose L., Sano, Kaori, Mena, Ignacio, Innis, Bruce L., Wirachwong, Ponthip, Thai, Duong Huu, Oliveira, Ricardo Das Neves, Scharf, Rami, Hjorth, Richard, Raghunandan, Rama, Krammer, Florian, García-Sastre, Adolfo, Palese, Peter

“…Rapid development of COVID-19 vaccines has helped mitigating SARS-CoV-2 spread, but more equitable allocation of vaccines is necessary to limit the global…”
Get full text

Genetic engineering employing MPB70 and its promoter enables efficient secretion and expression of foreign antigen in bacillus Calmette Guérin (BCG) Tokyo by Takeishi, Atsuki, Shaban, Amina K., Kakihana, Taichi, Takihara, Hayato, Okuda, Shujiro, Osada, Hidekazu, Suameitria Dewi, Desak Nyoman Surya, Ozeki, Yuriko, Yoshida, Yutaka, Nishiyama, Akihito, Tateishi, Yoshitaka, Aizu, Yuki, Chuma, Yasushi, Onishi, Kazuyo, Hayashi, Daisuke, Yamamoto, Saburo, Mukai, Tetsu, Ato, Manabu, Thai, Duong Huu, Nhi, Huynh Thi Thao, Shirai, Tsuyoshi, Shibata, Satoshi, Obata, Fumiko, Fujii, Jun, Yamayoshi, Seiya, Kiso, Maki, Matsumoto, Sohkichi

“…Vaccination is an important factor in public health. The recombinant bacillus Calmette Guérin (rBCG) vaccine, which expresses foreign antigens, is expected to…”
Get full text

Clinical testing of an inactivated influenza A/H5N1 vaccine candidate in a double-blinded, placebo-controlled, randomized trial in healthy adults in Vietnam by Phan, Trong Lan, Ho, Vinh Thang, Vu, Minh Huong, Nguyen, Tuyet Nga, Duong, Huu Thai, Holt, Renee, Wahid, Rahnuma, Donnelly, John, Flores, Jorge

“…Highlights • Increased capacity for pandemic influenza vaccine production is critical. • The vaccine developed by IVAC in Vietnam has proven to be safe and…”
Get full text

Randomized safety and immunogenicity trial of a seasonal trivalent inactivated split virion influenza vaccine (IVACFLU-S) in healthy young Vietnamese adults by Anh, Dang Duc, Thiem, Vu Dinh, Anh, Nguyen Thi Hien, Huong, Vu Minh, Nga, Nguyen Tuyet, Thang, Tran Cong, Thai, Duong Huu, Chien, Vien Chinh, Holt, Renee, Wahid, Rahnuma, Flores, Jorge, Berlanda Scorza, Francesco, Taylor, David N

“…Highlights • Increasing the world-wide capacity for manufacturing influenza vaccines is critical for appropriate preparedness. • IVAC, a Vietnam vaccine…”
Get full text

A phase 2/3 double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a seasonal trivalent inactivated split-virion influenza vaccine (IVACFLU-S) in healthy adults in Vietnam by Lan, Phan Trong, Toan, Nguyen Trong, Thang, Hoang Anh, Thang, Tran Cong, Be, Le Van, Thai, Duong Huu, Huong, Vu Minh, Nga, Nguyen Tuyet, Tang, Yuxiao, Holt, Renee, Francesco, Berlanda Scorza, Flores, Jorge, Tewari, Tushar

“…Background: Under the WHO's Global Action Plan for influenza vaccines, we conducted a phase 2-3 study of IVACFLU-S, a trivalent, seasonal inactivated influenza…”
Get full text